Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för P Roy Vagelos. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att P Roy Vagelos har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 125 493 |
US:THRX / Theseus Pharmaceuticals, Inc. | Director | 54 199 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av P Roy Vagelos. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp INVA / Innoviva, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i INVA / Innoviva, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i INVA / Innoviva, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av P Roy Vagelos som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −259 | 125 493 | −0,21 | ||||
2023-03-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | X | −25 000 | 312 578 | −7,41 | |||
2023-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −29 005 | 337 578 | −7,91 | 750,16 | −21 758 391 | 253 237 512 | |
2023-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 42 500 | 366 583 | 13,11 | 270,43 | 11 493 275 | 99 135 041 | |
2023-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −291 | 125 752 | −0,23 | ||||
2022-12-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
I - Other | −111 | 1 961 | −5,36 | 729,71 | −80 998 | 1 430 961 | |
2022-12-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
I - Other | −30 | 2 072 | −1,43 | 728,86 | −21 866 | 1 510 198 | |
2022-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 651 | 324 083 | 0,51 | ||||
2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −57 | 322 432 | −0,02 | 753,28 | −42 937 | 242 881 577 | |
2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −304 | 126 043 | −0,24 | ||||
2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −357 | 126 347 | −0,28 | ||||
2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | X | −23 077 | 322 489 | −6,68 | |||
2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −302 | 126 704 | −0,24 | ||||
2022-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 286 | 23 461 | −37,85 | 700,00 | −10 000 200 | 16 422 700 |
2022-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 286 | 127 006 | −10,11 | 700,02 | −10 000 486 | 88 906 740 |
2022-03-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −75 000 | 0 | −100,00 | ||||
2022-03-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −48 103 | 345 566 | −12,22 | 655,29 | −31 521 415 | 226 445 944 | |
2022-03-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 75 000 | 393 669 | 23,54 | 179,13 | 13 434 750 | 70 517 928 | |
2022-03-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −338 | 141 292 | −0,24 | ||||
2021-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
I - Other | −107 | 2 095 | −4,86 | 635,03 | −67 948 | 1 330 388 | |
2021-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
I - Other | −19 | 2 202 | −0,86 | 634,70 | −12 059 | 1 397 609 | |
2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 21 198 | 21 198 | |||||
2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 861 | 318 669 | 0,59 | ||||
2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −347 | 141 630 | −0,24 | ||||
2021-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −75 000 | 75 000 | −50,00 | ||||
2021-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −49 282 | 316 808 | −13,46 | 667,39 | −32 890 314 | 211 434 491 | |
2021-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 75 000 | 366 090 | 25,77 | 179,13 | 13 434 750 | 65 577 702 | |
2021-08-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 039 | 37 747 | −21,01 | 650,04 | −6 525 752 | 24 537 060 |
2021-08-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | X | −17 000 | 291 090 | −5,52 | |||
2021-08-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −373 | 141 977 | −0,26 | ||||
2021-08-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | X | −19 000 | 308 090 | −5,81 | |||
2021-08-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | X | −22 000 | 327 090 | −6,30 | |||
2021-08-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −446 | 142 350 | −0,31 | ||||
2021-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −248 079 | 0 | −100,00 | ||||
2021-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy) |
M - Exercise | −1 921 | 0 | −100,00 | ||||
2021-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −137 998 | 349 090 | −28,33 | 458,48 | −63 269 323 | 160 050 783 | |
2021-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 248 079 | 487 088 | 103,79 | 52,03 | 12 907 550 | 25 343 189 | |
2021-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 1 921 | 239 009 | 0,81 | 52,03 | 99 950 | 12 435 638 | |
2021-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −414 | 142 796 | −0,29 | ||||
2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 27 680 | 27 680 | |||||
2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 439 | 237 088 | 1,04 | ||||
2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | 2 406 | 3 609 | 200,00 | ||||
2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −2 406 | 47 786 | −4,79 | ||||
2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −349 | 143 210 | −0,24 | ||||
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −998 | 50 192 | −1,95 | 607,43 | −606 215 | 30 488 127 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 684 | 51 190 | −4,98 | 606,51 | −1 627 873 | 31 047 247 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 331 | 53 874 | −5,82 | 605,41 | −2 016 621 | 32 615 858 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 171 | 57 205 | −5,25 | 604,35 | −1 916 394 | 34 571 842 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 622 | 60 376 | −12,50 | 603,54 | −5 203 722 | 36 439 331 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 769 | 68 998 | −5,18 | 602,66 | −2 271 426 | 41 582 335 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 281 | 72 767 | −4,31 | 601,42 | −1 973 259 | 43 763 529 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 851 | 76 048 | −6,00 | 600,30 | −2 912 055 | 45 651 614 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −718 | 80 899 | −0,88 | 599,37 | −430 348 | 48 488 434 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −843 | 81 617 | −1,02 | 598,52 | −504 552 | 48 849 407 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −950 | 82 460 | −1,14 | 597,74 | −567 853 | 49 289 640 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −162 | 83 410 | −0,19 | 595,69 | −96 502 | 49 686 503 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −80 | 83 572 | −0,10 | 594,20 | −47 536 | 49 658 482 |
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −341 | 143 559 | −0,24 | ||||
2020-08-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | X | −73 100 | 234 649 | −23,75 | |||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 307 749 | −0,03 | 578,34 | −57 834 | 177 983 557 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −683 | 307 849 | −0,22 | 577,37 | −394 344 | 177 742 777 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −77 309 | 0 | −100,00 | |||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −77 309 | 0 | −100,00 | |||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −77 309 | 77 309 | −50,00 | |||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −77 309 | 154 618 | −33,33 | |||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy) |
M - Exercise | −3 264 | 0 | −100,00 | ||||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −433 | 143 900 | −0,30 | ||||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −564 | 144 333 | −0,39 | ||||
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −206 | 308 532 | −0,07 | 576,47 | −118 753 | 177 859 442 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 606 | 308 738 | −0,84 | 575,34 | −1 499 336 | 177 629 321 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 622 | 311 344 | −0,84 | 574,69 | −1 506 837 | 178 926 283 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 610 | 313 966 | −0,82 | 573,55 | −1 496 966 | 180 075 199 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 356 | 316 576 | −0,43 | 572,69 | −776 568 | 181 299 909 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 877 | 317 932 | −0,90 | 571,32 | −1 643 688 | 181 640 910 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 049 | 320 809 | −0,63 | 570,60 | −1 169 159 | 183 053 615 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 232 | 322 858 | −0,99 | 569,40 | −1 840 301 | 183 835 345 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 447 | 326 090 | −3,39 | 568,43 | −6 506 818 | 185 359 339 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 138 | 337 537 | −2,64 | 567,51 | −5 185 906 | 191 555 623 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 548 | 346 675 | −4,03 | 566,42 | −8 240 278 | 196 363 654 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 996 | 361 223 | −3,47 | 565,47 | −7 348 848 | 204 260 770 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 268 | 374 219 | −3,42 | 564,62 | −7 491 378 | 211 291 532 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 551 | 387 487 | −2,89 | 563,53 | −6 509 335 | 218 360 549 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 359 | 399 038 | −2,05 | 562,48 | −4 701 770 | 224 450 894 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 418 | 407 397 | −2,49 | 561,40 | −5 848 665 | 228 712 676 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 456 | 417 815 | −2,89 | 560,45 | −6 980 965 | 234 164 417 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 826 | 430 271 | −2,01 | 559,51 | −4 938 235 | 240 740 927 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 168 | 439 097 | −2,48 | 558,36 | −6 235 764 | 245 174 201 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 910 | 450 265 | −1,30 | 557,51 | −3 294 884 | 251 027 240 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 168 | 456 175 | −0,26 | 556,79 | −650 331 | 253 993 678 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | −39 720 | 457 343 | −7,99 | 570,97 | −22 678 928 | 261 129 133 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 77 309 | 497 063 | 18,42 | 30,63 | 2 367 975 | 15 225 040 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 77 309 | 497 063 | 18,42 | 30,63 | 2 367 975 | 15 225 040 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 77 309 | 497 063 | 18,42 | 30,63 | 2 367 975 | 15 225 040 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | −39 974 | 419 754 | −8,70 | 570,97 | −22 823 955 | 239 666 941 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | −39 974 | 419 754 | −8,70 | 570,97 | −22 823 955 | 239 666 941 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | −39 974 | 419 754 | −8,70 | 570,97 | −22 823 955 | 239 666 941 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 77 309 | 422 393 | 22,40 | 30,63 | 2 367 975 | 12 937 898 |
2020-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 3 264 | 307 749 | 1,07 | 30,63 | 99 976 | 9 426 352 | |
2019-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
I - Other | −126 | 2 200 | −5,42 | 375,31 | −47 289 | 825 682 | |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −33 | 304 485 | −0,01 | 379,14 | −12 512 | 115 442 443 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 602 | 304 518 | −1,17 | 378,38 | −1 362 925 | 115 223 521 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 732 | 308 120 | −1,83 | 377,47 | −2 163 658 | 116 306 056 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 060 | 313 852 | −3,99 | 376,36 | −4 915 262 | 118 121 339 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −21 910 | 326 912 | −6,28 | 375,55 | −8 228 300 | 122 771 802 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 873 | 348 822 | −1,93 | 374,79 | −2 575 932 | 130 734 997 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −632 | 355 695 | −0,18 | 373,26 | −235 900 | 132 766 716 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −107 655 | 0 | −100,00 | |||
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | −55 813 | 356 327 | −13,54 | 377,16 | −21 050 431 | 134 392 291 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 107 655 | 412 140 | 35,36 | 21,25 | 2 287 669 | 8 757 975 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Performance Stock Units |
A - Award | 9 086 | 9 086 | |||||
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 29 177 | 29 177 | |||||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 517 | 304 485 | −1,46 | 366,63 | −1 656 068 | 111 633 336 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 269 | 309 002 | −1,05 | 365,25 | −1 194 002 | 112 862 980 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 755 | 312 271 | −1,19 | 364,55 | −1 368 885 | 113 838 393 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 605 | 316 026 | −1,13 | 363,53 | −1 310 526 | 114 884 932 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 284 | 319 631 | −0,71 | 362,61 | −828 201 | 115 901 397 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 492 | 321 915 | −0,77 | 361,46 | −900 758 | 116 359 396 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −592 | 324 407 | −0,18 | 360,37 | −213 339 | 116 906 551 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 479 | 324 999 | −0,45 | 359,46 | −531 641 | 116 824 141 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −156 | 326 478 | −0,05 | 358,92 | −55 992 | 117 179 484 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −22 093 | 326 634 | −6,34 | ||||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −46 138 | 107 655 | −30,00 | |||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −14 000 | 348 727 | −3,86 | ||||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | −23 989 | 362 727 | −6,20 | 358,33 | −8 595 978 | 129 975 966 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 46 138 | 386 716 | 13,55 | 21,25 | 980 432 | 8 217 715 |
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −7 246 | 340 578 | −2,08 | ||||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −40 681 | 347 824 | −10,47 | ||||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −764 | 144 897 | −0,52 | ||||
2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −669 | 145 661 | −0,46 | ||||
2019-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −153 792 | 153 793 | −50,00 | ||||
2019-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −80 164 | 388 505 | −17,10 | 313,64 | −25 142 637 | 121 850 708 | |
2019-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 153 792 | 468 669 | 48,84 | 21,25 | 3 268 080 | 9 959 216 | |
2019-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −514 | 146 330 | −0,35 | ||||
2019-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −569 | 146 844 | −0,39 | ||||
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36 273 | 36 273 | |||||
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 | 2 304 | −0,26 | 382,32 | −2 294 | 880 865 | |
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −16 161 | 314 877 | −4,88 | ||||
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −19 202 | 331 038 | −5,48 | ||||
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −37 209 | 350 240 | −9,60 | ||||
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −521 | 147 413 | −0,35 | ||||
2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −12 500 | 387 449 | −3,13 | ||||
2018-08-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −210 | 307 585 | −0,07 | ||||
2018-08-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −108 | 399 949 | −0,03 | 374,46 | −40 442 | 149 764 903 | |
2018-08-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 210 | 400 057 | 0,05 | 21,25 | 4 462 | 8 501 211 | |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 399 847 | −0,07 | 371,29 | −111 387 | 148 459 193 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 400 147 | −0,02 | 370,17 | −37 017 | 148 122 415 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 194 | 400 247 | −3,19 | 369,41 | −4 873 996 | 147 855 244 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 211 | 413 441 | −2,87 | 368,61 | −4 501 097 | 152 398 487 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 405 | 425 652 | −1,48 | 367,40 | −2 353 197 | 156 384 545 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −24 339 | 432 057 | −5,33 | 366,49 | −8 920 000 | 158 344 570 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −17 221 | 456 396 | −3,64 | 365,56 | −6 295 309 | 166 840 122 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 473 617 | −0,19 | 364,75 | −328 275 | 172 751 801 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −153 274 | 0 | −100,00 | |||
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −78 604 | 474 517 | −14,21 | 370,52 | −29 124 354 | 175 818 039 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 153 274 | 553 121 | 38,33 | 16,80 | 2 575 003 | 9 292 433 |
2018-07-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −610 | 147 934 | −0,41 | ||||
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 399 847 | −0,05 | 336,87 | −67 374 | 134 696 459 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 400 047 | −0,07 | 335,01 | −100 503 | 134 019 745 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 400 347 | −0,12 | 333,15 | −166 575 | 133 375 603 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 300 | 400 847 | −0,32 | 332,80 | −432 640 | 133 401 882 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 402 147 | −0,02 | 331,09 | −33 109 | 133 146 850 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 096 | 402 247 | −0,76 | 330,32 | −1 022 671 | 132 870 229 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 854 | 405 343 | −3,07 | 329,51 | −4 235 522 | 133 564 572 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 426 | 418 197 | −2,89 | 328,45 | −4 081 320 | 137 356 805 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −19 393 | 430 623 | −4,31 | 327,48 | −6 350 820 | 141 020 420 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 594 | 450 016 | −3,35 | 326,57 | −5 092 533 | 146 961 725 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 047 | 465 610 | −1,70 | 325,67 | −2 620 666 | 151 635 209 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 473 657 | −0,11 | 324,18 | −162 090 | 153 550 126 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 474 157 | −0,08 | 323,97 | −129 588 | 153 612 643 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −153 274 | 153 274 | −50,00 | |||
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −78 564 | 474 557 | −14,20 | 333,07 | −26 167 311 | 158 060 700 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 153 274 | 553 121 | 38,33 | 16,80 | 2 575 003 | 9 292 433 |
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −616 | 148 544 | −0,41 | ||||
2018-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −557 | 149 160 | −0,37 | ||||
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 74 390 | 74 390 | |||||
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −153 969 | 0 | −100,00 | |||
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −74 860 | 399 847 | −15,77 | 383,29 | −28 693 089 | 153 257 357 |
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −8 805 | 474 707 | −1,82 | 383,29 | −3 374 868 | 181 950 446 |
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 153 969 | 483 512 | 46,72 | 21,92 | 3 375 000 | 10 598 583 |
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −91 | 149 717 | −0,06 | ||||
2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −477 | 149 808 | −0,32 | ||||
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −106 | 329 543 | −0,03 | 483,00 | −51 198 | 159 169 269 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −400 | 329 649 | −0,12 | 482,72 | −193 088 | 159 128 165 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 661 | 330 049 | −1,39 | 481,37 | −2 243 666 | 158 875 687 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 250 | 334 710 | −1,54 | 480,62 | −2 523 255 | 160 868 320 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −600 | 339 960 | −0,18 | 479,63 | −287 778 | 163 055 015 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 600 | 340 560 | −0,47 | 478,51 | −765 616 | 162 961 366 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 473 | 342 160 | −1,00 | 477,52 | −1 658 427 | 163 388 243 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 744 | 345 633 | −1,63 | 476,46 | −2 736 786 | 164 680 299 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 610 | 351 377 | −1,57 | 475,49 | −2 667 499 | 167 076 250 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 400 | 356 987 | −0,67 | 474,64 | −1 139 136 | 169 440 310 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −200 | 359 387 | −0,06 | 473,65 | −94 730 | 170 223 653 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −900 | 359 587 | −0,25 | 472,67 | −425 403 | 169 965 987 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −600 | 360 487 | −0,17 | 471,63 | −282 978 | 170 016 484 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −400 | 361 087 | −0,11 | 470,64 | −188 256 | 169 941 986 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −200 | 361 487 | −0,06 | 472,16 | −94 432 | 170 679 702 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 951 | 361 687 | −0,54 | 471,09 | −919 097 | 170 387 129 | |
2017-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −22 118 | 363 638 | −5,73 | 470,23 | −10 400 547 | 170 993 497 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 900 | 385 756 | −0,75 | 470,15 | −1 363 435 | 181 363 183 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 305 | 388 656 | −0,33 | 470,00 | −613 350 | 182 668 320 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −153 969 | 153 969 | −50,00 | ||||
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 986 | 389 961 | −2,74 | 470,17 | −5 165 288 | 183 347 963 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −75 406 | 400 947 | −15,83 | 471,41 | −35 547 142 | 189 010 425 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −7 159 | 476 353 | −1,48 | 471,41 | −3 374 824 | 224 557 568 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 153 969 | 483 512 | 46,72 | 21,92 | 3 375 000 | 10 598 583 | |
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −84 613 | 329 543 | −20,43 | ||||
2017-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −422 | 150 285 | −0,28 | ||||
2017-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −800 | 83 652 | −0,95 | 459,24 | −367 392 | 38 416 344 | |
2017-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 985 | 84 452 | −5,57 | 458,35 | −2 284 875 | 38 708 574 | |
2017-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 510 | 89 437 | −3,78 | 457,58 | −1 606 106 | 40 924 582 | |
2017-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −547 | 150 707 | −0,36 | ||||
2017-05-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −571 | 151 254 | −0,38 | ||||
2016-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 78 302 | 78 302 | |||||
2016-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −59 788 | 414 156 | −12,61 | ||||
2016-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −76 895 | 0 | −100,00 | ||||
2016-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −37 388 | 473 944 | −7,31 | 355,52 | −13 292 182 | 168 496 571 | |
2016-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −4 394 | 511 332 | −0,85 | 355,52 | −1 562 155 | 181 788 753 | |
2016-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 76 895 | 515 726 | 17,52 | 20,32 | 1 562 506 | 10 479 552 | |
2016-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −531 | 151 825 | −0,35 | ||||
2016-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −608 | 152 356 | −0,40 | ||||
2016-05-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −230 684 | 76 895 | −75,00 | ||||
2016-05-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −112 020 | 438 831 | −20,34 | 368,70 | −41 301 774 | 161 796 990 | |
2016-05-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −12 713 | 550 851 | −2,26 | 368,70 | −4 687 283 | 203 098 764 | |
2016-05-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 230 684 | 563 564 | 69,30 | 20,32 | 4 687 499 | 11 451 620 | |
2016-05-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −584 | 152 964 | −0,38 | ||||
2016-05-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −387 | 153 548 | −0,25 | ||||
2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 92 123 | 92 123 | |||||
2015-11-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 731 | 332 880 | −0,52 | ||||
2015-11-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 474 | 334 611 | −1,03 | 586,73 | −2 038 300 | 196 326 312 | |
2015-11-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 539 | 338 085 | −1,04 | 587,58 | −2 079 446 | 198 651 984 | |
2015-11-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 227 | 341 624 | −2,91 | 588,40 | −6 017 567 | 201 011 562 | |
2015-11-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −455 | 153 935 | −0,29 | ||||
2015-11-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 985 | 351 851 | −1,12 | 580,23 | −2 312 217 | 204 154 506 |
2015-11-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 257 | 355 836 | −3,59 | 580,18 | −7 691 446 | 206 448 930 |
2015-11-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −414 | 154 390 | −0,27 | ||||
2015-11-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −462 | 154 804 | −0,30 | ||||
2015-11-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −511 | 155 266 | −0,33 | ||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 108 380 | 108 380 | |||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −24 900 | 369 093 | −6,32 | ||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −591 | 155 777 | −0,38 | ||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −7 820 | 0 | −100,00 | ||||
2014-09-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 326 | 92 947 | −10,00 | 350,07 | −3 614 823 | 32 537 956 |
2014-09-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 | 103 273 | 0,00 | 351,00 | −702 | 36 248 823 |
2014-09-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 | 0 | −100,00 | ||||
2014-09-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 | 0 | −100,00 | ||||
2014-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −303 909 | 0 | −100,00 | ||||
2014-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −151 537 | 390 852 | −27,94 | 351,62 | −53 283 440 | 137 431 380 | |
2014-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −10 060 | 542 389 | −1,82 | 351,62 | −3 537 297 | 190 714 820 | |
2014-08-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 303 909 | 552 449 | 122,28 | 11,64 | 3 537 501 | 6 430 506 | |
2014-08-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 028 | 248 540 | −3,13 | 340,01 | −2 729 600 | 84 506 085 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −300 | 256 568 | −0,12 | 341,02 | −102 306 | 87 494 819 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −9 072 | 256 868 | −3,41 | 340,02 | −3 084 661 | 87 340 257 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 600 | 265 940 | −0,97 | 340,33 | −884 858 | 90 507 360 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −270 352 | 0 | −100,00 | ||||
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −135 108 | 268 540 | −33,47 | 340,12 | −45 952 933 | 91 335 825 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −7 543 | 403 648 | −1,83 | 340,12 | −2 565 525 | 137 288 758 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 270 352 | 411 191 | 191,96 | 9,49 | 2 565 640 | 3 902 203 | |
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −756 | 156 368 | −0,48 | ||||
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −700 | 157 124 | −0,44 | ||||
2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −764 | 157 824 | −0,48 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 562 | 0 | −100,00 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 705 | 0 | −100,00 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 921 | 0 | −100,00 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 952 | 0 | −100,00 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −8 591 | 0 | −100,00 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −42 148 | 0 | −100,00 | ||||
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 42 148 | 140 839 | 42,71 | 9,49 | 399 985 | 1 336 562 | |
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 591 | 98 691 | 9,53 | 11,64 | 99 999 | 1 148 763 | |
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 921 | 90 100 | 5,78 | 20,32 | 99 995 | 1 830 832 | |
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 562 | 85 179 | 5,66 | 21,92 | 99 999 | 1 867 124 | |
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 952 | 80 617 | 7,97 | 16,80 | 99 994 | 1 354 366 | |
2014-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 705 | 74 665 | 6,73 | 21,25 | 99 981 | 1 586 631 | |
2014-02-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 475 | 103 275 | −10,00 | 325,10 | −3 730 522 | 33 574 702 |
2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 127 500 | 127 500 | |||||
2013-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −95 | 2 257 | −4,04 | 296,11 | −28 130 | 668 320 | |
2013-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −679 | 158 588 | −0,43 | ||||
2013-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −73 596 | 1 | −100,00 | ||||
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 900 | 65 759 | −11,92 | 310,18 | −2 760 602 | 20 397 127 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 600 | 74 659 | −3,37 | 309,84 | −805 584 | 23 132 345 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 500 | 77 259 | −5,50 | 308,40 | −1 387 800 | 23 826 676 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 084 | 81 759 | −5,85 | 306,46 | −1 558 043 | 25 055 863 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 126 | 86 843 | −13,13 | 305,28 | −4 007 105 | 26 511 431 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 286 | 99 969 | −10,14 | 304,80 | −3 439 973 | 30 470 551 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 780 | 111 255 | −5,74 | 303,49 | −2 057 662 | 33 764 780 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 742 | 118 035 | −8,34 | 302,86 | −3 253 322 | 35 748 080 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 179 | 128 777 | −14,12 | 301,42 | −6 383 774 | 38 815 963 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −61 159 | 149 956 | −28,97 | 300,34 | −18 368 494 | 45 037 785 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −312 500 | 0 | −100,00 | |||
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −153 798 | 211 115 | −42,15 | 304,38 | −46 813 035 | 64 259 184 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −13 346 | 364 913 | −3,53 | 304,38 | −4 062 255 | 111 072 219 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 312 500 | 378 259 | 475,22 | 13,00 | 4 062 500 | 4 917 367 |
2013-09-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −921 | 159 267 | −0,57 | ||||
2013-05-22 |
|
4/A | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −12 018 | 114 750 | −9,48 | 263,15 | −3 162 537 | 30 196 462 | |
2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −732 | 114 018 | −0,64 | 264,19 | −193 387 | 30 122 415 | |
2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −12 750 | 114 750 | −10,00 | 263,15 | −3 355 162 | 30 196 462 | |
2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 215 | 160 188 | −0,75 | ||||
2013-05-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 254 | 161 403 | −0,77 | ||||
2012-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 150 000 | 150 000 | |||||
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −17 155 | 56 946 | −23,15 | 181,19 | −3 108 314 | 10 318 046 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 000 | 74 101 | −13,94 | 180,59 | −2 167 080 | 13 381 900 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −19 733 | 86 101 | −18,65 | 179,60 | −3 544 047 | 15 463 740 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 440 | 105 834 | −14,84 | 178,71 | −3 295 412 | 18 913 594 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 402 | 124 274 | −3,42 | 177,09 | −779 550 | 22 007 683 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 100 | 128 676 | −3,81 | 176,54 | −900 354 | 22 716 461 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 800 | 133 776 | −1,33 | 175,95 | −316 710 | 23 537 887 |
2012-11-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 004 | 135 576 | −4,91 | 175,03 | −1 225 910 | 23 729 867 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 890 | 142 580 | −2,66 | 176,18 | −685 340 | 25 119 744 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −32 356 | 146 470 | −18,09 | 175,19 | −5 668 448 | 25 660 079 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −28 507 | 178 826 | −13,75 | 175,12 | −4 992 146 | 31 316 009 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −312 500 | 0 | −100,00 | |||
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −127 417 | 207 333 | −38,06 | 175,00 | −22 297 975 | 36 283 275 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −34 696 | 334 750 | −9,39 | 175,00 | −6 071 800 | 58 581 250 |
2012-11-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 312 500 | 369 446 | 548,77 | 19,43 | 6 071 875 | 7 178 336 |
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 700 | 127 500 | −1,32 | 161,06 | −273 802 | 20 535 150 | |
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −30 800 | 129 200 | −19,25 | 160,59 | −4 946 172 | 20 748 228 | |
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 392 | 162 657 | −0,85 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −19 947 | 3 | −99,98 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −19 947 | 19 950 | −50,00 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −19 947 | 19 950 | −50,00 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −19 947 | 59 844 | −25,00 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 860 | 164 049 | −1,12 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 852 | 165 909 | −1,10 | ||||
2012-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 786 | 167 761 | −2,21 | ||||
2012-02-13 |
|
5 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 509 | 171 547 | −2,00 | ||||
2010-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 600 | 528 751 | −0,49 | 26,96 | −70 096 | 14 255 127 | |
2010-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −17 400 | 531 351 | −3,17 | 27,19 | −473 106 | 14 447 434 | |
2010-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −7 952 | 207 175 | −3,70 | ||||
2010-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −8 595 | 215 127 | −3,84 | ||||
2009-06-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
J - Other | −50 384 | 63 925 | −44,08 | ||||
2009-06-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
J - Other | 50 384 | 361 251 | 16,21 | ||||
2009-06-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −14 976 | 246 355 | −5,73 | ||||
2009-06-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −11 771 | 261 331 | −4,31 | ||||
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 2 000 | 54 199 | 3,83 | 10,22 | 20 440 | 553 914 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 800 | 52 199 | 1,56 | 10,21 | 8 168 | 532 952 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 600 | 51 399 | 3,21 | 10,20 | 16 320 | 524 270 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 200 | 49 799 | 0,40 | 10,20 | 2 039 | 507 701 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 500 | 49 599 | 1,02 | 10,19 | 5 095 | 505 414 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 200 | 49 099 | 0,41 | 10,18 | 2 037 | 500 073 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 100 | 48 899 | 2,30 | 10,18 | 11 198 | 497 792 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 300 | 47 799 | 0,63 | 10,17 | 3 051 | 486 116 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 100 | 47 499 | 0,21 | 10,15 | 1 015 | 482 115 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 400 | 47 399 | 0,85 | 10,14 | 4 056 | 480 626 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 100 | 46 999 | 0,21 | 10,14 | 1 014 | 476 335 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 400 | 46 899 | 0,86 | 10,13 | 4 052 | 475 087 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 2 800 | 46 499 | 6,41 | 10,58 | 29 624 | 491 959 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 2 600 | 43 699 | 6,33 | 10,57 | 27 482 | 461 898 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 4 600 | 41 099 | 12,60 | 10,56 | 48 576 | 434 005 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 3 800 | 36 499 | 11,62 | 10,55 | 40 090 | 385 064 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 500 | 32 699 | 4,81 | 10,54 | 15 810 | 344 647 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 600 | 31 199 | 1,96 | 10,53 | 6 318 | 328 525 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 700 | 30 599 | 5,88 | 10,52 | 17 884 | 321 901 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 000 | 28 899 | 3,58 | 10,51 | 10 510 | 303 728 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 100 | 27 899 | 0,36 | 10,50 | 1 050 | 292 940 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 300 | 27 799 | 1,09 | 10,49 | 3 147 | 291 612 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 2 554 | 27 499 | 10,24 | 10,48 | 26 766 | 288 190 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 046 | 24 945 | 4,38 | 10,47 | 10 952 | 261 174 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 1 300 | 23 899 | 5,75 | 10,46 | 13 598 | 249 984 | |
2008-03-17 |
|
4 | THRX |
THERAVANCE INC
Common Stock |
P - Purchase | 100 | 22 599 | 0,44 | 10,45 | 1 045 | 236 160 | |
2007-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
J - Other | X | −72 296 | 147 505 | −32,89 | |||
2007-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
J - Other | X | 72 296 | 75 629 | 2 169,10 | |||
2007-06-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −9 541 | 339 572 | −2,73 | ||||
2007-01-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 333 | 0 | −100,00 | ||||
2007-01-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 333 | 4 823 | 223,69 | 9,88 | 32 913 | 47 627 | |
2007-01-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | X | −10 529 | 349 113 | −2,93 | |||
2005-05-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
J - Other | X | −156 097 | 43 903 | −78,05 | |||
2005-05-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
J - Other | X | 156 097 | 157 225 | 13 838,39 | |||
2005-05-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | X | −39 292 | 465 220 | −7,79 |